Trademark: 88400241
Status Date
Tuesday, April 9, 2024
Filing Date
Wednesday, April 24, 2019
Published for Opposition
Tuesday, February 13, 2024
16 Medical identification cards, not magnetically encoded; medical identification cards, not magnetically encoded for use in connection with payment for prescription medication; discount prescription drug cards, not magnetically encoded
36 Advisory and consulting services in the field of pharmaceutical benefit management services; Health care and pharmacy benefits claims recovery services in the nature of insurance subrogation, namely, coordination of insurance benefits programs claims processing and administration; Insurance administration services, namely, insurance subrogation and assisting others with collecting insurance premiums in the nature of the collection of money owed by patients and insurance providers; pharmacy benefit management services; pharmacy benefit and claims processing management services; financial consulting services in the fields of healthcare benefits; financial consulting services in the fields of pharmacy and prescription medication benefits; consulting services in the field of pharmaceutical benefit management services; consulting services in the field of pharmaceutical benefit management services of Federal 340B pharmacy programs, and discount prescription drug programs
35 Advisory and consulting services in the field of cost management of health care and pharmaceuticals; Business advisory and consulting services in the field of health care and pharmaceutical benefit programs; pharmaceutical cost management advisory and consulting services regarding the administration of the federal 340B prescription drug discount program and maximization of benefits; providing an online computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes; data management services, namely, electronic data collection, online claims management, and financial reconciliation of accounts on behalf of others; administration coordination services in the nature of facilitating administrative coordination between health care facilities, pharmacies, and insurance plans; inventory management; Business consulting services in the fields of the business management and administration of Federal 340B pharmacy programs and discount prescription drug programs; business management and administration of Federal 340B pharmaceutical programs and discount prescription drug programs; Business and Inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business and inventory management services provided to eligible pharmacies for controlling drug inventories; business assistance, advisory services, and consultancy in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; business consulting services, relating to operations management services, managing the flow of inventory, business information, and accounts receivable billing between health centers, pharmacies, wholesalers, and insurance companies; business assistance, advisory services, and consultancy, namely, assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; audit support services, namely, audit policy and procedures guidance, review of audit documents, data and procedures, preparation, organization, and presentation of the documents and data requested by a government body or third party, and providing business advice on government or third party audit processes, policies, and strategies; specialty retail pharmacy services; interactive record-keeping services for use in regulatory compliance by professionals in the healthcare, medical and pharmaceutical fields; consulting services in the field of pharmaceutical cost management services and drug utilization review services; business consulting services in the fields of pharmacy and prescription medication benefits; business consulting services in the field of healthcare benefits
45 Regulatory compliance consulting in the fields of healthcare, pharmaceutical, Federal 340B pharmacy programs, and discount prescription drug programs; regulatory compliance consulting services in the fields of healthcare, pharmaceuticals and Federal 340B pharmaceutical program in the nature of compliance, auditing, and reviewing contracts, systems, procedures, and policies, all for compliance with government regulations; reviewing standards and practices to assure compliance with laws and regulations relating to healthcare and pharmaceutical benefit plans; regulatory compliance consulting in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies; advisory and consulting services in the field of health care and pharmaceutical regulatory compliance
44 Advisory and consulting services in the field of health care; Medical and pharmaceutical consultation
42 Software as a Service (SAAS) services featuring software for use with managing medical and pharmaceutical records and data; computer services, namely, providing search engine services for obtaining and managing medical and pharmaceuticals records and data on a global computer network; Software as a Service (SAAS) services featuring software for cost management in the field of health care and pharmaceuticals; software as a service (SAAS) services featuring software for use with self-auditing company records to ensure compliance with, and maximizing the benefits of, health care and pharmaceutical benefit programs; software as a service (SAAS) services featuring software for administering and maximizing the use of the federal 340B prescription drug discount program through organization of information and implementation of automated duty allocation, automated risk scoring, and expert-defined tasks and assessment steps
Apr 9, 2024
Noa E-Mailed - Sou Required From Applicant
Feb 13, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 13, 2024
Published For Opposition
Jan 24, 2024
Notification Of Notice Of Publication E-Mailed
Jan 5, 2024
Approved For Pub - Principal Register
Jan 5, 2024
Teas/Email Correspondence Entered
Jan 5, 2024
Correspondence Received In Law Office
Nov 22, 2023
Teas Response To Suspension Inquiry Received
May 26, 2023
Notification Of Letter Of Suspension E-Mailed
May 26, 2023
Letter Of Suspension E-Mailed
May 26, 2023
Suspension Letter Written
Apr 18, 2023
Notification Of Letter Of Suspension E-Mailed
Apr 18, 2023
Letter Of Suspension E-Mailed
Apr 18, 2023
Suspension Letter Written
Mar 17, 2023
Teas/Email Correspondence Entered
Mar 16, 2023
Correspondence Received In Law Office
Mar 16, 2023
Teas Response To Office Action Received
Dec 20, 2022
Notification Of Non-Final Action E-Mailed
Dec 20, 2022
Non-Final Action E-Mailed
Dec 20, 2022
Non-Final Action Written
Nov 8, 2022
Notification Of Letter Of Suspension E-Mailed
Nov 8, 2022
Letter Of Suspension E-Mailed
Nov 8, 2022
Suspension Letter Written
Oct 4, 2022
Teas/Email Correspondence Entered
Oct 4, 2022
Correspondence Received In Law Office
Oct 4, 2022
Teas Response To Office Action Received
Aug 10, 2022
Notification Of Non-Final Action E-Mailed
Aug 10, 2022
Non-Final Action E-Mailed
Aug 10, 2022
Non-Final Action Written
Mar 9, 2022
Report Completed Suspension Check Case Still Suspended
Aug 13, 2021
Report Completed Suspension Check Case Still Suspended
Jan 21, 2021
Report Completed Suspension Check Case Still Suspended
Jun 29, 2020
Report Completed Suspension Check Case Still Suspended
Dec 6, 2019
Notification Of Letter Of Suspension E-Mailed
Dec 6, 2019
Letter Of Suspension E-Mailed
Dec 6, 2019
Suspension Letter Written
Nov 14, 2019
Teas/Email Correspondence Entered
Nov 14, 2019
Correspondence Received In Law Office
Nov 14, 2019
Teas Response To Office Action Received
Jun 13, 2019
Notification Of Non-Final Action E-Mailed
Jun 13, 2019
Non-Final Action E-Mailed
Jun 13, 2019
Non-Final Action Written
Jun 5, 2019
Assigned To Examiner
May 9, 2019
New Application Office Supplied Data Entered
Apr 27, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
